UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16
OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of March 2019
Commission file number:001-38775
ITAMAR MEDICAL LTD.
(Name of registrant)
9 Halamish Street, Caesarea 3088900, Israel
(Address of principal executive office)
_____________________
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-FxForm 40-F¨
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):¨
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):¨
____________________
EXPLANATORY NOTE
Itamar Medical Ltd. hereby furnishes the presentation, scheduled to be presented at the Oppenheimer 29th Annual Healthcare Conference on March 20, 2019, which is attached to this Form 6-K as Exhibit 99.1.
Exhibits
Exhibit Number | Description |
| 99.1 | Itamar Medical Ltd., investor presentation, March 2019, scheduled to be presented at the Oppenheimer 29th Annual Healthcare Conference on March 20, 2019. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| ITAMAR MEDICAL LTD. | |||
| By: | /s/ Shy Basson | ||
| Shy Basson | |||
| Chief Financial Officer | |||
| Date: March 19, 2019 | |||